DK2533637T3 - Chromoninhibitorer af S-nitrosoglutathionreduktase - Google Patents
Chromoninhibitorer af S-nitrosoglutathionreduktaseInfo
- Publication number
- DK2533637T3 DK2533637T3 DK10845917.3T DK10845917T DK2533637T3 DK 2533637 T3 DK2533637 T3 DK 2533637T3 DK 10845917 T DK10845917 T DK 10845917T DK 2533637 T3 DK2533637 T3 DK 2533637T3
- Authority
- DK
- Denmark
- Prior art keywords
- chromone
- inhibitors
- nitrosoglutathione reductase
- nitrosoglutathione
- reductase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2010/024035 WO2011099978A1 (en) | 2010-02-12 | 2010-02-12 | Chromone inhibitors of s-nitrosoglutathione reductase |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2533637T3 true DK2533637T3 (da) | 2014-05-19 |
Family
ID=44368022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10845917.3T DK2533637T3 (da) | 2010-02-12 | 2010-02-12 | Chromoninhibitorer af S-nitrosoglutathionreduktase |
Country Status (5)
Country | Link |
---|---|
US (4) | US8481590B2 (da) |
EP (1) | EP2533637B1 (da) |
JP (1) | JP5639665B2 (da) |
DK (1) | DK2533637T3 (da) |
WO (1) | WO2011099978A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101188435B (zh) * | 2007-01-08 | 2011-03-16 | 中兴通讯股份有限公司 | 一种比特交织装置与方法 |
SG10201500895XA (en) | 2009-11-05 | 2015-04-29 | Rhizen Pharmaceuticals Sa | Chromen-4-one Derivatives As Kinase Modulators |
US8481590B2 (en) | 2010-02-12 | 2013-07-09 | N30 Pharmaceuticals, Inc. | Chromone inhibitors of S-nitrosoglutathione reductase |
AU2011215833B2 (en) | 2010-02-12 | 2015-07-09 | Nivalis Therapeutics, Inc. | Novel S-nitrosoglutathione reductase inhibitors |
US20140094465A1 (en) * | 2011-06-10 | 2014-04-03 | N30 Pharmaceuticals, Inc. | Compounds as S-Nitrosoglutathione Reductase Inhibitors |
WO2016055947A1 (en) * | 2014-10-07 | 2016-04-14 | Glenmark Pharmaceuticals S.A. | Alkyne compounds as s-nitrosoglutathione reductase inhibitors |
WO2020264156A1 (en) | 2019-06-25 | 2020-12-30 | Musc Foundation For Research Development | Asymmetric dimethylarginine (adma) as a marker for vascular pathologies |
IT202200007988A1 (it) * | 2022-04-22 | 2023-10-22 | Fondazione St Italiano Tecnologia | Derivati del 4-cromone come inibitori della polimerasi ¿ come agenti antitumorali e metodo per la loro preparazione |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8626344D0 (en) | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
WO1997031007A1 (en) | 1996-02-21 | 1997-08-28 | Glycomed Incorporated | SIALYL LEWISx MIMETICS CONTAINING FLAVANOID BACKBONES |
JP2000506161A (ja) | 1996-03-05 | 2000-05-23 | インペリアル カレッジ オブ サイエンス テクノロジー アンド メディシン | スルファメート基を有する化合物 |
US6057367A (en) | 1996-08-30 | 2000-05-02 | Duke University | Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses |
US5919813C1 (en) | 1998-03-13 | 2002-01-29 | Univ Johns Hopkins Med | Use of a protein tyrosine kinase pathway inhibitor in the treatment of diabetic retinopathy |
KR100295206B1 (ko) | 1998-08-22 | 2001-07-12 | 서경배 | 디아릴벤조피란유도체및이를함유하는시클로옥시게네이즈-2저해제조성물 |
US7144880B2 (en) | 1999-04-30 | 2006-12-05 | Regents Of The University Of Michigan | Compositions relating to novel compounds and targets thereof |
WO2001080855A1 (en) | 2000-04-27 | 2001-11-01 | Geron Corporation | Telomerase inhibitors and methods of their use |
US7049308B2 (en) | 2000-10-26 | 2006-05-23 | Duke University | C-nitroso compounds and use thereof |
US7179791B2 (en) | 2001-01-11 | 2007-02-20 | Duke University | Inhibiting GS-FDH to modulate NO bioactivity |
AUPR255401A0 (en) | 2001-01-16 | 2001-02-08 | Novogen Research Pty Ltd | Regulation of lipids and/or bone density and compositions therefor |
US20030181510A1 (en) | 2002-03-19 | 2003-09-25 | Robert Baker | Inhibition of muscle regeneration following myectomy |
CN1671373A (zh) | 2002-06-27 | 2005-09-21 | 人类生物研究基金公司 | 用于抑制aldh的化合物 |
US20050080024A1 (en) | 2002-08-15 | 2005-04-14 | Joseph Tucker | Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
AU2003282999A1 (en) | 2002-10-22 | 2004-05-13 | Jenken Biosciences, Inc. | Chromones and chromone derivatives and uses thereof |
CA2528155A1 (en) | 2003-06-04 | 2005-01-06 | Duke University | Compositions and methods for modulating s-nitrosoglutathione reductase |
CN1241921C (zh) | 2003-07-09 | 2006-02-15 | 东华大学 | 含氟异黄酮衍生物、制造方法及其用途 |
AU2005233614C1 (en) | 2004-04-08 | 2012-07-19 | Armetheon, Inc. | Materials and methods for treating coagulation disorders |
RU2335501C2 (ru) * | 2004-04-08 | 2008-10-10 | Арикс Терапьютикс | Средства и способы для лечения нарушений свертываемости |
US20060247305A1 (en) * | 2005-03-11 | 2006-11-02 | Regents Of The University Of Michigan | Chromen-4-one inhibitors of anti-apoptotic Bcl-2 family members and the uses thereof |
KR101431279B1 (ko) | 2005-07-29 | 2014-08-20 | 리스버로직스 코퍼레이션 | 복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달 |
GB0618168D0 (en) | 2006-09-15 | 2006-10-25 | Babraham Inst | Compounds |
AU2007314141A1 (en) | 2006-10-30 | 2008-05-08 | Novogen Research Pty Ltd | Prevention and reversal of chemotherapy-induced peripheral neuropathy |
WO2009026657A1 (en) | 2007-08-29 | 2009-03-05 | The University Of Sydney | Flavonoid ppar agonists |
EP2581451B1 (en) * | 2007-12-13 | 2016-03-09 | Indiana University Research and Technology Corporation | Compounds for inhibiting mammalian s-nitrosoglutathione reductase |
WO2010107476A1 (en) | 2009-03-19 | 2010-09-23 | Duke University | Inhibiting gsnor |
US8481590B2 (en) | 2010-02-12 | 2013-07-09 | N30 Pharmaceuticals, Inc. | Chromone inhibitors of S-nitrosoglutathione reductase |
AU2011215833B2 (en) | 2010-02-12 | 2015-07-09 | Nivalis Therapeutics, Inc. | Novel S-nitrosoglutathione reductase inhibitors |
US20140094465A1 (en) | 2011-06-10 | 2014-04-03 | N30 Pharmaceuticals, Inc. | Compounds as S-Nitrosoglutathione Reductase Inhibitors |
-
2010
- 2010-02-12 US US13/521,820 patent/US8481590B2/en not_active Expired - Fee Related
- 2010-02-12 WO PCT/US2010/024035 patent/WO2011099978A1/en active Application Filing
- 2010-02-12 DK DK10845917.3T patent/DK2533637T3/da active
- 2010-02-12 EP EP10845917.3A patent/EP2533637B1/en not_active Not-in-force
- 2010-02-12 JP JP2012552848A patent/JP5639665B2/ja not_active Expired - Fee Related
-
2013
- 2013-06-07 US US13/912,287 patent/US8669381B2/en not_active Expired - Fee Related
-
2014
- 2014-01-30 US US14/168,595 patent/US20140163092A1/en not_active Abandoned
-
2015
- 2015-08-14 US US14/826,329 patent/US9717706B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20150352073A1 (en) | 2015-12-10 |
US9717706B2 (en) | 2017-08-01 |
WO2011099978A1 (en) | 2011-08-18 |
EP2533637A1 (en) | 2012-12-19 |
EP2533637A4 (en) | 2013-07-17 |
US8669381B2 (en) | 2014-03-11 |
JP2013519670A (ja) | 2013-05-30 |
US20120295966A1 (en) | 2012-11-22 |
US20130274320A1 (en) | 2013-10-17 |
JP5639665B2 (ja) | 2014-12-10 |
US20140163092A1 (en) | 2014-06-12 |
EP2533637B1 (en) | 2014-03-26 |
US8481590B2 (en) | 2013-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201600021B (it) | Nuovi composti di chinolina sostituiti come inibitori della s-nitrosoglutatione reduttasi | |
CY2019026I1 (el) | Μη νουκλεοσιδικοι αναστολεις αναστροφης μεταγραφασης | |
SMT201500271B (it) | Inibitori di neprilisina | |
DK3357511T3 (da) | Inhibitorer af t-celleaktivering | |
HK1178742A1 (zh) | -亞硝基谷胱甘肽還原酶的新抑制劑 | |
DOP2012000114A (es) | Inhibidor bromodominio de benzodiazepina | |
CO7010824A2 (es) | Inhibidores de aplicación viral | |
DK2912019T3 (da) | Heteroarylhæmmere af pde4 | |
DK2528602T4 (da) | Formuleringer af bendamustin | |
CR20120576A (es) | Inhibidores de pirazolil quinazolina cinasa | |
DK2526425T3 (da) | Fremgangsmåde til diagnosticering af endometriel receptivitet | |
DK2558105T3 (da) | Bardoxolonmethyl til behandling af fedme | |
DK2603232T3 (da) | Stabile formuleringer af linaclotid | |
BR112013014952A2 (pt) | inibidores de neprilisina | |
DK2555704T3 (da) | Visning af hæmostatiske parametre | |
DK2533637T3 (da) | Chromoninhibitorer af S-nitrosoglutathionreduktase | |
DK2506840T3 (da) | Anvendelser af hæmmere af hypoksi-fremkaldende faktorer | |
DK2315590T3 (da) | Pyrrolinhibitorer af S-nitrosoglutathionreduktase | |
DK2800572T3 (da) | Sammensætning af ellagitannin-rige ekstrakter | |
BR112013014681A2 (pt) | novos compostos aromáticos bicíclicos substituídos como inibidores de s-nitrosoglutationa redutase | |
DK2632475T3 (da) | Sammensætninger til behandling af perifere sår af forskellig oprindelse | |
DK2516435T3 (da) | Inhibitorer af AKT-aktivitet | |
ITTO20110268A1 (it) | Composizione di maquillage. | |
IT1402120B1 (it) | Composizione di malta. | |
DK2888228T3 (da) | Inhibitorer af CD40-TRAF6 interaktion |